Skip to Content

Saratoga Health & Biotechnology I SBHIX Fund Analysis

| Medalist Rating as of | See Saratoga Investment Hub

Morningstar’s Analysis SBHIX

Will SBHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Saratoga Health& Biotechnology I's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor